Risk Management Strategy and Innovation in Pharmacovigilance

Tuesday, 11 October 2016, Amsterdam, Hyatt Place Amsterdam Airport

Official language: English

Download the brochure

Risk Management Strategy and Innovation in Pharmacovigilance

2016 will be a very challenging year for all people dealing with safety of drugs, biologics and devices.

Further to the EMA-projects the compliance with regulatory guidance becomes much more complicated and pragmatic approaches are key.

The conference will take you through the implementation of a Risk management strategy with a particular focus on technologies and tools. Session dedicated to Innovation in Pharmacovigilance, Quality & Compliance in PV; Risk management plans; Inspections/Audit Findings are foreseen too.

Scientific Board

Joyce de Langen, Senior Solution Manager Pharmacovigilance, Elsevier

Who should attend?

The seminar is ideally suited for employees of small-, middle- and large-sized companies in the pharmaceutical sector especially concerned with the implementation and/or maintenance of Pharmacovigilance/Vigilance Systems, with its critical processes and quality system. Participants may come from various departments involved in fulfilling Pharmacovigilance/Vigilance requirements as legal Medical Affairs and Regulatory Affairs.

Cookies help us deliver our services. By using our services, you agree to our use of cookies. Learn more